Navigation Links
Severe asthma may be a different form of the disease
Date:1/28/2008

BETHESDA, Md. (Jan. 28, 2008) − A multi-center research project to investigate severe asthma has found a key physiological difference between severe and non-severe forms of the disease, a finding that could help explain why those with severe asthma do not respond well to treatment.

The study from the Severe Asthma Research Program (SARP) has found that those with severe asthma are much more likely to show signs of air trapping in the lungs, a condition that prevents a full exhalation. The study also found that those who have severe asthma are more likely to have airway obstruction even after maximal treatment. The results suggest that those who suffer severe asthma have a different form of the disease.

SARP was formed to look for an underlying cause of severe asthma, because it is not responding to treatment, said Ronald Sorkness, a physiologist at the University of Wisconsin in Madison and the lead author of the study, Lung Function in Adults with Stable but Severe asthma: Air Trapping and Incomplete Reversal of Obstruction with Bronchodilation. Understanding the pathophysiology of severe asthma and improving its treatment is the goal of SARP.

The study, which appears online in the Journal of Applied Physiology, compared lung function measurements from 287 people with severe asthma and 382 people with mild and moderate (non-severe) forms of the disease.

Living with asthma

There is much that is still unknown about asthma. For example, it is not clear why more women than men have asthma, and why the reverse is true among children. SARP is an ongoing project that has collected data and examined various aspects of asthma, including the role that genes and viruses may play in its onset.

Most asthma cases, 90-95%, can be controlled with medication. But the remaining 5-10% are the people who suffer a severe form of the disease that doesnt respond well to treatment. People who have severe asthma are
'/>"/>

Contact: Christine Guilfoy
cguilfoy@the-aps.org
301-634-7253
American Physiological Society
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Yale discovery suggests protein may play a role in severe asthma
2. Cell transplants may improve severe urinary incontinence
3. In the laboratory, green tea proves a powerful medicine against severe sepsis
4. Severely restricted diet linked to physical fitness into old age
5. Extended wakefulness, combined with alcohol, severely impairs driving performance
6. HATS off to combat asthma
7. Asthma link to post-traumatic stress disorder, says Mailman School of Public Health study
8. Study finds a high rate of asthma in college athletes
9. Survey finds elevated rates of new asthma among WTC rescue and recovery workers
10. Bodily breakdown explained: How cell differentiation patterns suppress somatic evolution
11. Mechanism for regulation of growth and differentiation of adult muscle stem cells is revealed

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...ILADELPHIA Exposure to secondhand smoke for a pro...rease the risk of breast cancer, even in women who...stion of whether exposure to side-stream smoke cou...nresolved," said Peggy Reynolds, Ph.D., senior res...Center,s Berkeley office. "While no single epidemi...
(Date:12/2/2009)...N - A team comprised of undergraduate students fro...honors in a national poster contest hosted by the ...ng (ISPE). , The annual contest highlights the r...t month at the ISPE Annual Meeting in San Diego, C...f a Posterior Criciate Ligament Tensioning Device,...
(Date:12/2/2009)...w study on the smokeless tobacco product called mo...entists in Minnesota to urge the tobacco industry ...s content of carcinogens. Their study is published... in Toxicology . It reports that this category of ... of certain toxic and cancer-causing substances. C...
Breaking Biology News(10 mins):Exposure to secondhand cigarette smoke over a lifetime increased breast cancer risk later in life 2 244 million NCI grant funds comparative effectiveness research at Southwest Oncology Group 59516 1 244 million NCI grant funds comparative effectiveness research at Southwest Oncology Group 59516 2 244 million NCI grant funds comparative effectiveness research at Southwest Oncology Group 59516 3Brown and beige dominate the plate 3A Daily dose of color needed to fill Americas phytonutrient gap 10372 1Brown and beige dominate the plate 3A Daily dose of color needed to fill Americas phytonutrient gap 10372 2Brown and beige dominate the plate 3A Daily dose of color needed to fill Americas phytonutrient gap 10372 3Brown and beige dominate the plate 3A Daily dose of color needed to fill Americas phytonutrient gap 10372 4Bug barcode readers hold out promise of universal vaccines 10368 1Bug barcode readers hold out promise of universal vaccines 10368 2
...s such as honeybees and bumble bees are predictabl...ving directly from one flower to an adjacent clust... flight paths have a direct affect on their abilit...tilization and seed production that results when p...f gene flow has experienced more attention in part...
...2009) -- Patients suffering from a blood disorder ... new medication that may dramatically improve thei... and 100,000 individuals in the U.S. diagnosed wit...n autoimmune disease that dramatically reduces the...ises, nosebleeds and, rarely, life-threatening bra...
...March 20, 2009 Ecopsychologyan emerging field th...mental issues and ways in which ecology and psycho...levelsis the focus of a new online peer-reviewed j...r Mary Ann Liebert, Inc. this spring ( www.liebert... relationship between environmental issues and men...
Other Biology News:Flight of the bumble (and honey) bee 2Lancet study supports new, highly effective treatment for blood disorder 2Lancet study supports new, highly effective treatment for blood disorder 3New ecopsychology journal will premiere in spring 2009 2
(Date:12/3/2009)...re-FirstCall/ -- Inverness Medical Innovations, In...ividuals to take charge of their health at home th...anagement, has declared a dividend of $3.00 per sh...d Stock ( IMA-PB). The dividend will be paid in sh...l to the quotient of (a) $3.00 divided by (b) 97% ...
(Date:12/2/2009)...e/ -- Reportlinker.com announces that a new market..., Neurostimulation - A Global Market Perspectiv...rostimulation---A-Global-Market-Perspective.html ...thused by the growing base of aging population, an...as, Parkinson,s, and Alzheimer,s disease. Widespre...
(Date:12/2/2009)...wire-FirstCall/ -- Peregrine Pharmaceuticals, Inc....ient enrollment in a dose confirmation and dosimet... glioblastoma multiforme (GBM), the deadliest form... antibody linked to a radioisotope being developed...cifically targets cells at the center of brain tum...
(Date:12/2/2009)...ember 2 Gamida Cell announced toda...animal study) safety and,efficacy of a gene therap...nell Medical College and Gamida Cell. The product ... as Cooley,s Anemia. , Gamida Cell is dev...o,populations of stem/progenitor cells. The compa...
Breaking Biology Technology:Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3
...lar, a pioneer in,the development of cost-effectiv...as granted Gen-Probe Incorporated (Nasdaq: GPRO )... Xceed,s novel Flow-Thru Chip,technology. Gen-Prob... its,next-generation multiplexed molecular-diagnos... development, manufacture, and marketing of rapid,...
...nues of 7 Billion Swiss Francs 300...e 3 With 148 biotech companies and 72,suppliers t...iness --,Switzerland has the world,s highest biote... foreign investment agency Location Promotion,Swit...hese firms employ,14,000 people and have an annual...
...arches for surgeons, MONTVALE, N.J., June 3 Cont...rmation dedicated to enhancing the surgeon,s,pract...ne tool:,SURGERYFINDIT.COM ( http://www.SURGERYFIN...tinued commitment to provide,general surgeons with...a,and practice information, Contemporary Surgery h...
Other Biology Technology:Xceed Molecular Grants Gen-Probe License to Xceed's Flow-Thru Chip(R) Technology for Multiplex Molecular Diagnostics 2220 Companies Place Switzerland First in Biotech Density Per Capita 2220 Companies Place Switzerland First in Biotech Density Per Capita 3SURGERYFINDIT.COM and Convera(R) Launch Vertical Search Site for Surgeons 2
Rabbit Anti-Human Evi-1 Polyclonal Antibody, Unconjugated from Cell Signaling Technology
...s the basic components required for the developmen...inant mouse Dickkopf homolog-1 (Dkk-1) in cell cul...cient materials to run ELISAs on approximately fif...onditions are met: The assay is run as summarized...
pCDF-1 Expression System plus Competent Cells from Novagen
Chicken Anti-Human Uridine Phosphorylase 1 Polyclonal Antibody, Unconjugated from Abcam
Biology Products: